In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 ...

In a clinical trial, the company's weight loss pill resulted in a nearly 12% weight loss at 72 weeks for participants who took the highest dose of the medication. On average, participants lost 7.8% to ...

Now, new clinical trial results suggest that an oral form of this medication may be coming soon—and the results so far are ...

Eli Lilly says a new pill for obesity, similar to existing GLP-1 medications that can only be injected, is showing promise in a clinical trial.

In eagerly awaited results from a new study, the pharmaceutical company Eli Lilly reports that a pill its scientists ...

GLP-1 drugs have shifted from medical to mainstream, and the impact is rippling far beyond health. From luxury to lifestyle, ...

Linda Yaccarino, former CEO of X (formerly Twitter) and ex-NBCUniversal ad exec, has reappeared as the CEO of eMed Population ...

Linda Yaccarino, the former X CEO who left the social media company last month in the wake of yet another Elon Musk ...

Yaccarino, who has a house in Woodbury, graduated from Deer Park High in 1981 with her twin sister, Lori. Both were elected ...

Even though Novo Nordisk warned that copycat versions of its obesity and diabetes drugs would hurt sales in the U.S., second-quarter sales saw a 67% rise year on year. More news covers telehealth ...

Despite not coming from a healthcare background, Yaccarino brings over a decade of experience in digital revenue and brand ...